Yahoo Web Search

Search results

1. • 

     How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

     CNBC· 3 days ago

     Skyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...

2. • Final Section 1557 Rules: Highlights for Health Plan Sponsors | JD Supra

     JD Supra· 20 hours ago

     The new rules apply to certain group health plans, as well as many health care providers. The nondiscrimination rules apply to employer-sponsored group health plans that receive funding from ...

3. • 

     Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say

     New Hampshire Union Leader· 5 days ago

     Months into a new Biden administration policy intended to lower drug costs for Medicare patients,...

4. • US Drug Negotiations Plan Shifts Focus for Rare Disease Programs

     Bloomberg Law· 3 days ago

     The rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development of drugs to treat ...

5. • Gateway - Quartz

     Quartz· 3 days ago

     Novo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma giant is one-half ...